SELLAS Life Sciences (SLS) Income from Continuing Operations (2020 - 2023)
Historic Income from Continuing Operations for SELLAS Life Sciences (SLS) over the last 7 years, with Q4 2023 value amounting to -$8.2 million.
- SELLAS Life Sciences' Income from Continuing Operations rose 1343.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 972.82%. This contributed to the annual value of -$37.9 million for FY2023, which is 830.97% up from last year.
- Latest data reveals that SELLAS Life Sciences reported Income from Continuing Operations of -$8.2 million as of Q4 2023, which was up 1343.43% from -$9.4 million recorded in Q3 2023.
- Over the past 5 years, SELLAS Life Sciences' Income from Continuing Operations peaked at -$2.2 million during Q1 2021, and registered a low of -$16.7 million during Q1 2022.
- In the last 4 years, SELLAS Life Sciences' Income from Continuing Operations had a median value of -$7.7 million in 2022 and averaged -$7.6 million.
- Per our database at Business Quant, SELLAS Life Sciences' Income from Continuing Operations surged by 4475.89% in 2021 and then plummeted by 64543.43% in 2022.
- SELLAS Life Sciences' Income from Continuing Operations (Quarter) stood at -$4.2 million in 2020, then tumbled by 179.37% to -$11.6 million in 2021, then grew by 18.7% to -$9.4 million in 2022, then grew by 13.43% to -$8.2 million in 2023.
- Its Income from Continuing Operations was -$8.2 million in Q4 2023, compared to -$9.4 million in Q3 2023 and -$9.0 million in Q2 2023.